News

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.